SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
82.70 -0.87  -1.04% NYSE Arca Sep 18, 16:59 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 83.55
Discount or Premium to NAV 0.03%
Turnover Ratio 45.00%
1 Year Fund Level Flows -739.86M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.35% 1.21% -0.13% 18
3M -2.09% -2.25% 1.16% 21
6M -8.44% -8.48% -3.24% 84
YTD 16.47% 15.98% 9.68% 9
1Y -11.30% -11.19% -6.12% 86
3Y 9.09% 9.08% 8.51% 45
5Y 9.85% 9.84% 7.34% 15
10Y 16.37% 16.37% 13.87% 11
15Y -- -- 10.63% --
20Y -- -- 10.08% --
As of Sept. 17, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.08% 0.08% 0.00%
Stock 99.92% 99.92% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 16, 2019

Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Sept. 16, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Sept. 16, 2019

Stock Market Capitalization

Giant 2.84%
Large 8.45%
Medium 21.65%
Small 59.29%
Micro 7.77%
As of Sept. 16, 2019

Stock Style Exposure

Large Cap Value 6.12%
Large Cap Blend 4.37%
Large Cap Growth 1.59%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 23.16%
Small Cap Value 6.68%
Small Cap Blend 17.18%
Small Cap Growth 40.90%
As of Sept. 16, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
ACAD ACADIA Pharmaceuticals Inc 2.54% 42.30 -0.70%
IMMU Immunomedics Inc 1.99% 16.93 -2.92%
GHDX Genomic Health Inc 1.98% 71.08 -0.41%
MDCO The Medicines Co 1.88% 47.34 -0.73%
ALNY Alnylam Pharmaceuticals Inc 1.72% 85.56 -2.57%
PTLA Portola Pharmaceuticals Inc 1.72% 30.11 -2.14%
NBIX Neurocrine Biosciences Inc 1.65% 101.08 -0.33%
EBS Emergent BioSolutions Inc 1.62% 53.30 -0.04%
NVTA Invitae Corp 1.61% 21.50 +0.05%
AMGN Amgen Inc 1.56% 194.97 -0.89%
As of Sept. 16, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Karl Schneider 4.50 yrs
Michael Feehily 7.50 yrs
Raymond Donofrio 2.32 yrs

Net Fund Flows

1M 43.99M
3M -200281.8
6M -40.93M
YTD -98.52M
1Y -739.86M
3Y 1.165B
5Y 1.974B
10Y 2.036B
As of Aug. 31, 2019

Risk Info

Beta (5Y) 1.677
Max Drawdown (All) 49.25%
Historical Sharpe Ratio (10Y) 0.7428
Historical Sortino (All) 0.7925
30-Day Rolling Volatility 26.13%
Daily Value at Risk (VaR) 1% (All) 4.80%
Monthly Value at Risk (VaR) 1% (All) 20.43%

Fundamentals

Dividend Yield TTM (9-18-19) 0.24%
30-Day SEC Yield (9-16-19) -0.03%
7-Day SEC Yield --
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 6.633
Weighted Average Price to Book Ratio 4.116
Weighted Median ROE -15.80%
Weighted Median ROA -19.47%
Forecasted Dividend Yield 0.21%
Forecasted PE Ratio 16.38
Forecasted Price to Sales Ratio 2.146
Forecasted Price to Book Ratio 3.181
Number of Holdings 119
As of Sept. 17, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 19.72%
Forecasted Book Value Growth 4.91%
Forecasted Cash Flow Growth 21.03%
Forecasted Earnings Growth 16.86%
Forecasted Revenue Growth 15.08%
As of Sept. 17, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 1/31/2006
Termination Date
Last Annual Report Date 6/30/2019
Last Prospectus Date 10/31/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.